TG Therapeutics, Inc. (Nasdaq: TGTX) is up 5% after-hours after the company announced preliminary clinical results from its ongoing Phase ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE